1. The Lancet Public Health
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study 
Gayatri Amirthalingam, MFPH, Nick Andrews, PhD, Philip Keel, MSc, David Mullett, MA, Ana Correa, MSc, Simon de Lusignan, MD, Mary Ramsay, FFPH 
The Lancet Public Health 
DOI: /S (17)
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

2. Figure 1
Cumulative coverage for each age cohort throughout 3-year vaccination programme
Cohorts are grouped by age on Sept 1, 2013.
The Lancet Public Health DOI: ( /S (17) )
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

3. Figure 2
Observed zoster incidence and model-predicted incidence in the absence of vaccination by year for each age cohort
Cohorts are grouped by age on Sept 1, Each year range runs from Sept 1 of the first year to Aug 31 of the second. Blue points indicate observed zoster incidence and red points indicate observed incidence in age cohorts eligible for vaccination. Green lines show the model-predicted incidence in the absence of vaccination.
The Lancet Public Health DOI: ( /S (17) )
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions